Status:
UNKNOWN
Real World Study of Immune Checkpoint Inhibitors for Advanced Gastric Cancer
Lead Sponsor:
Sun Yat-sen University
Conditions:
Gastric Cancer
Eligibility:
All Genders
16-80 years
Brief Summary
Gastric cancer ranks as the fifth most common and the third most common cause of cancer deaths in the world. In spite of the progresses made in the diagnosis and treatment of gastric cancer in the pas...
Eligibility Criteria
Inclusion
- age above 16, male or female.
- patients with gastric cancer confirmed by pathology through tumor biopsy or puncture tissue.
- the patient was assessed as untreatable by surgery.
- patients received first line, second-line or third-line chemotherapy and were treated with immunne checkpoint inhibitors.
- the patient had complete preliminary pathological information, tumor site, pathological type and other information.
- the patient must have adequate tumor tissue or 5-10 FFPE white tablets to provide; After treatment, patients were returned to the hospital for re-examination every 3 treatment cycles, and plasma and peripheral blood samples could be obtained during the whole process.
- other indicators of the patients met the general clinical trial enrollment conditions.
- subjects read and fully understand the instructions to patients, and sign the informed consent.
- \-
Exclusion
- Patients who cannot provide peripheral blood samples prior treatment.
- Patients with severe infection will be excluded.
- Patients with other serious disease besides gastric cancer will be excluded.
- Pregnant women will be excluded.
- Patients who are alcoholic or drug abusers will be excluded.
- Patients with a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data will be excluded.
Key Trial Info
Start Date :
December 12 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 20 2020
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT04086888
Start Date
December 12 2016
End Date
June 20 2020
Last Update
September 12 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China, 510060
2
Sun Yat-sen University Cancer Center
Guanzhou, Guangdong, China, 510060